107 related articles for article (PubMed ID: 953903)
1. Tartrazine-containing drugs.
Bartle WR
Can Med Assoc J; 1976 Aug; 115(4):332-3. PubMed ID: 953903
[TBL] [Abstract][Full Text] [Related]
2. Tartrazine: a potentially hazardous dye in Canadian drugs.
MacCara ME
Can Med Assoc J; 1982 Apr; 126(8):910-4. PubMed ID: 7074487
[TBL] [Abstract][Full Text] [Related]
3. Tartrazine (FD & C yellow #5) anaphylaxis: a case report.
Desmond RE; Trautlein JJ
Ann Allergy; 1981 Feb; 46(2):81-2. PubMed ID: 7469134
[TBL] [Abstract][Full Text] [Related]
4. Allergic reactions due to F D and C Yellow No. 5, tartrazine, an aniline dye used as a coloring and identifying agent in various steroids.
LOCKEY SD
Ann Allergy; 1959; 17():719-21. PubMed ID: 14417794
[No Abstract] [Full Text] [Related]
5. [Color additives in drugs].
Laake K; Westby O; Berg C
Tidsskr Nor Laegeforen; 1980 Apr; 100(12):699. PubMed ID: 7414582
[No Abstract] [Full Text] [Related]
6. Tartrazine sensitivity.
Dipalma JR
Am Fam Physician; 1990 Nov; 42(5):1347-50. PubMed ID: 2239641
[TBL] [Abstract][Full Text] [Related]
7. Allergic dermatitis due to aniline dye additive.
Prout J
Proc R Soc Med; 1973 Mar; 66(3):261-2. PubMed ID: 4266847
[No Abstract] [Full Text] [Related]
8. Drugs containing tartrazine dye.
Smith LJ; Slavin RG
J Allergy Clin Immunol; 1976 Oct; 58(4):456-70. PubMed ID: 972214
[No Abstract] [Full Text] [Related]
9. [Skin disease morbidity characteristics among workers in the aniline dye industry].
Timchenko AN; Pliashkun IV; Laptev IF
Vestn Dermatol Venerol; 1979 Aug; (8):42-6. PubMed ID: 158906
[No Abstract] [Full Text] [Related]
10. [A case of allergy to paraphenyldiamine].
PRISCO A
Folia Med (Napoli); 1957 Dec; 40(12):1154-63. PubMed ID: 13524313
[No Abstract] [Full Text] [Related]
11. [Current problems in improving periodic medical examinations in machine manufacturing and aniline dye industries].
Dynnik VI; Kleĭner AI; Baranenko AA; Abramovich-Poliakov DK; Anastovskaia VS
Gig Tr Prof Zabol; 1981 Jul; (7):45-6. PubMed ID: 7286697
[No Abstract] [Full Text] [Related]
12. [Prohibit coloring agents in drugs].
Berglund F
Lakartidningen; 2004 Feb; 101(7):615. PubMed ID: 15024882
[No Abstract] [Full Text] [Related]
13. [Urticaria--angioedema induced by non-steroidal anti-inflammatory analgesics].
Díez Gómez ML; Alvarez Cuesta E; Hinojosa Macías M; García Cañadillas F; Alcover Sánchez R
Allergol Immunopathol (Madr); 1984; 12(3):179-88. PubMed ID: 6332509
[TBL] [Abstract][Full Text] [Related]
14. Sulfite content of drug products.
Dalton-Bunnow MF
Am J Hosp Pharm; 1985 Oct; 42(10):2196-201. PubMed ID: 4061462
[TBL] [Abstract][Full Text] [Related]
15. [Pharmaceutical preparations which contain tartrazine].
Alvarez Cuesta E; Alcover Sánchez R; Sainz Martín T; Anaya Turrientes M; García Rodríguez D
Allergol Immunopathol (Madr); 1981; 9(1):45-54. PubMed ID: 7258046
[TBL] [Abstract][Full Text] [Related]
16. [The significance of paraphenylenediamine (PPD) hypersensitivity in the occupational eczema of barbers].
Zschunke E; Folesky H; Krüger J
Z Gesamte Hyg; 1970 Jul; 16(7):537-9. PubMed ID: 4252067
[No Abstract] [Full Text] [Related]
17. Additives contained in drug formulations most frequently prescribed in Switzerland.
Kolly M; Pécoud A; Frei PC
Ann Allergy; 1989 Jan; 62(1):21-5. PubMed ID: 2912321
[TBL] [Abstract][Full Text] [Related]
18. [Hygienic characteristics of aniline dyes used in preparation of toys].
VASENINA NT
Gig Sanit; 1955 Jan; 1():29-32. PubMed ID: 14366271
[No Abstract] [Full Text] [Related]
19. Tartrazine-containing drugs.
Lee M; Gentry AF; Schwartz R
Drug Intell Clin Pharm; 1981 Oct; 15(10):782-8. PubMed ID: 7285797
[TBL] [Abstract][Full Text] [Related]
20. [Cyanosis caused by aniline poisoning].
MARTY J; RENNER R; LESTAGE J
Bull Mens Soc Med Mil Fr; 1954 Nov; 48(9):233-4. PubMed ID: 13230752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
